New stem cell transplant could reduce dangerous side effects in blood cancer patients
NCT ID NCT05735717
First seen Apr 07, 2026 · Last updated Apr 30, 2026 · Updated 4 times
Summary
This study tests a new type of stem cell transplant for children and adults with blood cancers like leukemia. The transplant uses a special process to remove certain immune cells, aiming to lower the risk of graft-versus-host disease (a serious complication where donor cells attack the patient's body). The goal is to see if this approach is safe and helps patients recover without long-term need for anti-rejection drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Minnesota Masonic Cancer Center
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact
Conditions
Explore the condition pages connected to this study.